On September 4, Everpure rose 5.25% in regular trading, trading at $97.22/share, with turnover of $104 million. The continued rally was driven by the company's strong fiscal Q2 results and a wave of analyst upgrades.

Everpure reported fiscal Q2 adjusted EPS of $0.70, beating the consensus estimate of $0.58 by approximately 20.7% and representing a 62.8% year-over-year increase from $0.43. Revenue came in at $1.19 billion, topping the $1.10 billion estimate. The company also raised its full-year fiscal 2027 revenue guidance to $5.03-$5.07 billion, far exceeding the prior Street consensus of $4.50 billion, while Q3 revenue guidance of $1.325-$1.335 billion similarly surpassed the $1.135 billion estimate.

Following the results, BofA Securities upgraded Everpure to Buy from Neutral and raised its price target to $150 from $90. Wedbush lifted its target to $130, maintaining an Outperform rating and noting the raised guidance is \"still very beatable.\" Morgan Stanley upgraded the stock to Overweight, while Susquehanna moved to a Positive rating with a $120 target. Additionally, a second hyperscaler design and supply agreement announced in August is expected to be a significant revenue contributor starting in fiscal 2028.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)